Opus Point Partners Management as of Sept. 30, 2015
Portfolio Holdings for Opus Point Partners Management
Opus Point Partners Management holds 55 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| SPDR S&P Biotech (XBI) | 29.6 | $54M | 863k | 62.25 | |
| iShares NASDAQ Biotechnology Index (IBB) | 3.4 | $6.1M | 20k | 303.35 | |
| Clovis Oncology | 3.0 | $5.4M | 59k | 91.96 | |
| Incyte Corporation (INCY) | 2.9 | $5.2M | 47k | 110.34 | |
| Alexion Pharmaceuticals | 2.9 | $5.2M | 33k | 156.39 | |
| Celgene Corporation | 2.8 | $5.1M | 47k | 108.17 | |
| Biogen Idec (BIIB) | 2.8 | $5.1M | 18k | 291.81 | |
| Alkermes (ALKS) | 2.8 | $5.1M | 87k | 58.67 | |
| Medivation | 2.8 | $5.0M | 118k | 42.50 | |
| Illumina (ILMN) | 2.8 | $5.0M | 28k | 175.83 | |
| Regeneron Pharmaceuticals (REGN) | 2.7 | $4.9M | 11k | 465.14 | |
| Nektar Therapeutics (NKTR) | 2.7 | $4.9M | 444k | 10.96 | |
| Seattle Genetics | 2.6 | $4.8M | 125k | 38.56 | |
| BioMarin Pharmaceutical (BMRN) | 2.4 | $4.4M | 42k | 105.33 | |
| Bio-techne Corporation (TECH) | 2.4 | $4.3M | 47k | 92.47 | |
| Mettler-Toledo International (MTD) | 2.4 | $4.3M | 15k | 284.74 | |
| AstraZeneca (AZN) | 2.4 | $4.3M | 136k | 31.82 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.4 | $4.3M | 41k | 104.14 | |
| Qiagen | 2.3 | $4.1M | 160k | 25.80 | |
| ISIS Pharmaceuticals | 2.3 | $4.1M | 101k | 40.42 | |
| Cepheid | 2.2 | $4.1M | 90k | 45.20 | |
| Alnylam Pharmaceuticals (ALNY) | 2.1 | $3.9M | 48k | 80.35 | |
| Agios Pharmaceuticals (AGIO) | 1.8 | $3.2M | 46k | 70.59 | |
| Bristol Myers Squibb (BMY) | 1.2 | $2.1M | 36k | 59.19 | |
| Merck & Co (MRK) | 1.1 | $2.0M | 41k | 49.39 | |
| Proshares Tr pshs ult nasb (BIB) | 1.1 | $1.9M | 33k | 58.26 | |
| Hologic (HOLX) | 1.0 | $1.9M | 48k | 39.12 | |
| Nanostring Technologies (NSTGQ) | 0.9 | $1.6M | 102k | 16.00 | |
| Novavax | 0.8 | $1.4M | 200k | 7.07 | |
| Array BioPharma | 0.6 | $1.1M | 250k | 4.56 | |
| Flamel Technologies | 0.5 | $926k | 57k | 16.31 | |
| Vericel (VCEL) | 0.5 | $900k | 332k | 2.71 | |
| Zogenix | 0.5 | $887k | 66k | 13.50 | |
| Pacira Pharmaceuticals (PCRX) | 0.5 | $863k | 21k | 41.10 | |
| Amgen (AMGN) | 0.4 | $778k | 5.6k | 138.29 | |
| Curis | 0.4 | $757k | 375k | 2.02 | |
| United Therapeutics Corporation (UTHR) | 0.4 | $731k | 5.6k | 131.22 | |
| Achillion Pharmaceuticals | 0.4 | $733k | 106k | 6.91 | |
| D Stemline Therapeutics | 0.4 | $662k | 75k | 8.83 | |
| Epizyme | 0.3 | $593k | 46k | 12.87 | |
| Chimerix (CMRX) | 0.3 | $541k | 14k | 38.23 | |
| Merrimack Pharmaceuticals In | 0.3 | $528k | 62k | 8.51 | |
| Repros Therapeutics | 0.3 | $494k | 98k | 5.04 | |
| Gilead Sciences (GILD) | 0.2 | $424k | 4.3k | 98.08 | |
| Axovant Sciences | 0.2 | $397k | 31k | 12.92 | |
| Infinity Pharmaceuticals (INFIQ) | 0.2 | $383k | 45k | 8.45 | |
| Arrowhead Research | 0.2 | $295k | 51k | 5.77 | |
| Ophthotech | 0.2 | $290k | 7.2k | 40.56 | |
| National Holdings | 0.1 | $246k | 90k | 2.75 | |
| Direxion Shs Etf Tr sp biotch bull | 0.1 | $241k | 15k | 16.23 | |
| Acelrx Pharmaceuticals | 0.1 | $176k | 58k | 3.05 | |
| Karyopharm Therapeutics (KPTI) | 0.1 | $155k | 15k | 10.51 | |
| XenoPort | 0.1 | $139k | 40k | 3.48 | |
| Assembly Biosciences | 0.1 | $143k | 15k | 9.53 | |
| D Fluidigm Corp Del (LAB) | 0.1 | $122k | 15k | 8.13 |
